menu
    • menu

    Company profile for GenSight Biologics

    NEW Drugs in Dev: 4
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are an innovative clinical-stage gene therapy company currently focused on discovering, developing and commercializing novel therapies for patients with severe retinal neurodegenerative diseases.Our mission is to turn scientific advances in gene therapy into novel treatments for patients with severe degenerative diseases of the eye and the central nervous system. Our initial focus is on severe retinal diseases, with the goa...
    We are an innovative clinical-stage gene therapy company currently focused on discovering, developing and commercializing novel therapies for patients with severe retinal neurodegenerative diseases.Our mission is to turn scientific advances in gene therapy into novel treatments for patients with severe degenerative diseases of the eye and the central nervous system. Our initial focus is on severe retinal diseases, with the goal of preserving or restoring vision in patients who suffer from sight-threatening ophthalmic diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GenSight BiologicsFrance Flag
    Country
    Country
    France
    Address
    Address
    74, rue du Faubourg Saint-Antoine 75012 Paris
    Telephone
    Telephone
    +33 1 76 21 72 20
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gensight-biologics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/gensight-biologics-sa?trk=prof-exp-company-name
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/gensightbio?lang=fr

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Asia Pharma Expo

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gensight Biologics Reveals Outcome Of January 28, 2026 Meeting
    Gensight Biologics Reveals Outcome Of January 28, 2026 Meeting

    28 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260128489702/en/GenSight-Biologics-Announces-the-Results-of-its-Extraordinary-General-Meeting-of-January-28-2026

    BUSINESSWIRE
    28 Jan 2026
    Share Share
    Gensight Biologics Discloses Cash Status And Business Updates
    Gensight Biologics Discloses Cash Status And Business Updates

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108106511/en/GenSight-Biologics-Reports-Cash-Position-as-of-December-31-2025-and-Provides-Business-Updates

    BUSINESSWIRE
    08 Jan 2026
    Share Share
    Gensight Bio Gains Early Access For Gene Therapy In Israel
    Gensight Bio Gains Early Access For Gene Therapy In Israel

    31 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/clinical-trials/gensight-biologics-gets-early-access-nod-for-candidate-gene-therapy-in-israel-18726

    INDPHARMAPOST
    31 Dec 2025
    Share Share
    GenSight Secures Early Access for LUMEVOQ in Israel
    GenSight Secures Early Access for LUMEVOQ in Israel

    22 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251222028829/en/GenSight-Biologics-Announces-Regulatory-Authorization-for-Early-Access-Treatment-with-GS010LUMEVOQ-in-Israel

    BUSINESSWIRE
    22 Dec 2025
    Share Share
    Gensight Biologics Grants Compassionate Use For GS010/LUMEVOQ
    Gensight Biologics Grants Compassionate Use For GS010/LUMEVOQ

    22 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251221464508/en/GenSight-Biologics-Announces-the-Granting-of-Compassionate-Use-Authorization-CUAAAC-for-GS010LUMEVOQ-in-France

    BUSINESSWIRE
    22 Dec 2025
    Share Share
    France Approves GenSight's REVISE Dose-Ranging Study
    France Approves GenSight's REVISE Dose-Ranging Study

    02 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251202055055/en/GenSight-Biologics-Announces-Regulatory-Approval-for-GS010LUMEVOQ-REVISE-Dose-Ranging-Study-in-France

    BUSINESSWIRE
    02 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search